Chemtrack Lifesciences Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 10 Year, 7 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth -41.10%
- Profit Growth -25.55%
- Ebitda -23.71%
- Net Worth 16.67%
- Total Assets 31.86%
About Chemtrack Lifesciences
Chemtrack Lifesciences Private Limited (CLPL) is a Private Limited Indian Non-Government Company incorporated in India on 28 July 2014 and has a history of Ten years and seven months. Its registered office is in Hyderabad, Telangana, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Vasanthalaxmi Vidap and Naresh Chidurala serve as directors at the Company.
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24100TG2014PTC095057
- Company No.
095057
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
28 Jul 2014
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Pharma
Who are the key members and board of directors at Chemtrack Lifesciences?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vasanthalaxmi Vidap  | Director | 01-Feb-2018 | Current |
| Naresh Chidurala | Director | 28-Jul-2014 | Current |
Financial Performance of Chemtrack Lifesciences.
Chemtrack Lifesciences Private Limited, for the financial year ended 2021, experienced significant reduction in revenue, with a 41.1% decrease. The company also saw a substantial fall in profitability, with a 25.55% decrease in profit. The company's net worth Soared by an impressive increase of 16.67%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Chemtrack Lifesciences?
In 2021, Chemtrack Lifesciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Hp Chem City Private LimitedNaresh Chidurala is a mutual person
Nayva Chem Biopharma Private LimitedVasanthalaxmi Vidap and Naresh Chidurala are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Chemtrack Lifesciences?
Unlock and access historical data on people associated with Chemtrack Lifesciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Chemtrack Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Chemtrack Lifesciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
